WOBURN, Mass. , June 28, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Bradley M. Fluegel to its Board of Directors, effective as of July 1, 2022 . Mr. Fluegel has a broad commercial and advisory background with concentrated industry experience in

NeuroMetrix Announces WellMed Medical Management’s Integration of NC-stat® DPNCheck™ Into Their Patient Evaluation Program WALTHAM, Mass. --(BUSINESS WIRE)--May. 15, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the

NeuroMetrix Announces Warrant Redemption WALTHAM, Mass. --(BUSINESS WIRE)--Mar. 13, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes, today announced plans to redeem warrants to purchase an aggregate

WOBURN, Mass. , Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announced important updates to its Quell ® 2.0 commercial strategy.  This novel wearable device

WOBURN, Mass. , June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced that Shai N. Gozani , M.D., Ph.D., President and CEO, will participate in a panel titled "Roadmap to FDA Approval" on Tuesday, January 5 at the 2016 CES Event in Las Vegas . The panel moderator is Alfred Poor , Editor of

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell is available for purchase at FSAstore.com and HSAstore.com , the only e-commerce sites stocked exclusively with eligible products for Flexible Spending Account (FSA) and Health Savings Account (HSA)

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO,NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ will be featured on the November 26 th episode of The Henry Ford Innovation Nation which airs on the CBS network on Saturday mornings as part of its "CBS

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® will be featured in the Target Open House in San Francisco . "We are delighted that Target has added Quell to their Open House concept," said Frank McGillin, SVP and General Manager, Consumer of

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ is featured in the new Thrive Global commerce platform, including the online store at ThriveGlobal.com and Retail Pop Up Experience in New York City from